# OnCo record arog-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/arog-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "arog-pharmaceuticals" ;
  schema:name "Arog Pharmaceuticals"@en ;
  schema:alternateName "Arog Pharmaceuticals, Inc."@en, "AROG"@en ;
  schema:description "Arog is a private Dallas biotech developing crenolanib, a FLT3 and PDGFR kinase inhibitor, through phase 3 trials in FLT3-mutant acute myeloid leukaemia and gastrointestinal stromal tumours."@en ;
  schema:url <https://onco.cc/companies/arog-pharmaceuticals/>, <https://www.arogpharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.arogpharma.com>, <https://clinicaltrials.gov/search?lead=Arog%20Pharmaceuticals%2C%20Inc.>, <https://www.wikidata.org/wiki/Q30286808> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/gist/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .